Abstract

BackgroundPolymorphisms in Vitamin D receptor (FokI (VDR-F) and BsmI (VDR-B)), Estrogen receptor (Pvu II (ESR1P) and Xba I (ESR1X)), Collagen type1 (SpI (COL1A1) and Calcitonin Receptor (Alu I (CTR)) are...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Correlation of estrogen receptor alpha gene polymorphisms and bone mineral density in Chinese women with chronic periodontitis.
Yin Long ... Hao Wu
Chinese Medical Journal | VOL. 123
Yin Long, et. al.Yin Long ... Hao Wu
01 Nov 2010
AB0326 IMPACT OF ANTI-CITRULLINATED PROTEIN ANTIBODIES AND RHEUMATOID FACTOR ON BONE MINERAL DENSITY CHANGE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH DENOSUMAB
H Nakamura ... T Koike
Annals of the Rheumatic Diseases | VOL. 82
H Nakamura, et. al.H Nakamura ... T Koike
30 May 2023
Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women.
Jung Gu Kim ... Young Min Choi
Menopause (New York, N.Y.) | VOL. 8
Jung Gu Kim, et. al.Jung Gu Kim ... Young Min Choi
01 May 2001
The relationship between educational level and bone mineral density in postmenopausal women
Ayşegül Jale Sarac ... Ali Gur
BMC Family Practice | VOL. 5
Ayşegül Jale Sarac, et. al.Ayşegül Jale Sarac ... Ali Gur
06 Sep 2004
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers